Investor Sues Biopharma Co. Over Study Disclosure
Biopharmaceutical company Geron Corp. and two of its executives face a federal securities lawsuit in New Jersey accusing them of publicizing deceptively selective details of a clinical study for the company's...To view the full article, register now.
Already a subscriber? Click here to view full article